On the Brink of Legalization in California, Cannabis Company Stocks Should Soar
Source: Clive Maund for Streetwise Reports  (12/18/17)
Technical analyst Clive Maund provides an argument for why two cannabis companies are poised for big gains following the legalization of recreational marijuana in the state of California.
More >

COT Report: Predictably Stomach Churning but Bullish
Source: Michael Ballanger for Streetwise Reports  (12/18/17)
Precious metals expert Michael Ballanger explains why he finds gold stocks "dirt cheap." More >

The Perfect Gold Stock for Revivalists
Source: Clive Maund for Streetwise Reports  (12/15/17)
Technical analyst Clive Maund charts a young gold company that he believes "is going places." More >

Cannabis Biotech Stock Starting to Advance Again
Source: Clive Maund for Streetwise Reports  (12/15/17)
A technical analysis by Clive Maund on CliveMaund.com has a Buy on this cannabis biotech stock. More >

New Uranium Assays Improve 'Resource Confidence'
Source: Streetwise Reports  (12/14/17)
David Talbot, an analyst with Eight Capital, outlined recent drill results from this energy company's flagship asset.
More >

Precious Metals Explorer to Acquire 'District-Scale Gold Properties'
Source: Streetwise Reports  (12/14/17)
Craig Stanley, an analyst with Eight Capital, took a look at the terms and potential of this mining company's prospective transactions in Ontario.
More >

Metallic Minerals Catches the Silver Ring
Source: Bob Moriarty for Streetwise Reports  (12/14/17)
Silver is cheap right now, says Bob Moriarty of 321 Gold, who profiles a company in the Yukon that he says is delivering world-class exploration results. More >

Micro-Cap Oil & Gas Explorer's First Permian Basin Well Flowing 465 Barrels/Day
Source: Streetwise Reports  (12/13/17)
Exploration is just beginning for this oil and gas E&P with large tracts of prime land in the Permian Basin in Texas. More >

'The Market Gets it Wrong, Again'; Analyst Raises Target Price on Biotech
Source: Streetwise Reports  (12/13/17)
Ed Arce, an analyst with H.C. Wainwright & Co., explained the positive elements of this drug developer's recently released clinical trial data and why they did not warrant the market reaction they got.
More >

Bitcoin Total Wipeout Alert
Source: Clive Maund for Streetwise Reports  (12/13/17)
Technical analyst Clive Maund discusses why he thinks Bitcoin is about to take a dive. More >

Guyana Shield Is Host to Multiple Gold Deposits
Source: Streetwise Reports  (12/12/17)
As two Guyana projects begin commercial gold production, a new mineral resource estimate is in the works for a third project. More >

Junior Miner Looking Good for Commercial Production in 2018, Analysts Say
Source: Streetwise Reports  (12/12/17)
A flagship Nevada project is showing results and the company anticipates commencing commercial production in the first quarter of 2018. More >

Gold Major to Increase Dividend by 50% in 2018
Source: Streetwise Reports  (12/11/17)
BMO Capital Markets reported on this miner's outlook for 2018 and beyond.
More >

Jack Chan's Weekly Precious Metals Market Update
Source: Jack Chan for Streetwise Reports  (12/11/17)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets.
More >

Cryptojunkies: Beware the Ides of December
Source: Michael J. Ballanger for Streetwise Reports  (12/11/17)
As Bitcoin futures are set to begin trading next week, precious metals expert Michael Ballanger discusses movements in gold and cryptocurrencies. More >

Keith Barron Wants to Mine U3O8 'Cheep'
Source: Bob Moriarty for Streetwise Reports  (12/11/17)
More mining companies should follow the example of the garimpeiro miners of Brazil who mine until they fail to make a profit, says Bob Moriarty of 321 Gold, who discusses one gold and one uranium company that may be changing the paradigm. More >

Positive Drill Results Confirm Large-Scale Potential for Nevada Lithium Project
Source: The Critical Investor for Streetwise Reports  (12/10/17)
Drill results from a Nevada lithium project caught the attention of The Critical Investor. More >

Zinc Explorer Finally Hits at Zone 3; How Big Can the Resource Get?
Source: The Critical Investor for Streetwise Reports  (12/9/17)
The Critical Investor provides an update on this zinc explorer's latest drill results. More >

A New Breed of Regenerative Therapy Companies Taking Hold
Source: Hunter Diamond, CFA for Streetwise Reports  (12/7/17)
A regenerative therapy company with expertise in both cell therapy development and manufacturing, and a potential treatment for diabetes, differentiates this company, says Hunter Diamond, CFA, CEO of Diamond Equity Research. More >

'Prospective Explorer' Working Toward Maiden Resource
Source: Streetwise Reports  (12/7/17)
Cormark Securities provided an update on this company's gold project in central Wyoming. More >

Biotech Delivers 'Great' Phase 2 Data in NASH
Source: John McCamant for Streetwise Reports  (12/7/17)
John McCamant of the Medical Technology Stock Letter raised his target price on this company given the earning potential of a once-a-day oral treatment for liver disease in what could be a $35 billion market.
More >

Two 100%-Owned Projects Have Analysts Talking About a Possible 'JV Partnership Offer'
Source: Streetwise Reports  (12/7/17)
With an advanced project being looked at by potential partners and a newer project producing precious metal results, several analysts rate this precious metals explorer a "Buy." More >

A Gold Explorer's Productive November Has Analysts Saying 'Buy'
Source: Streetwise Reports  (12/7/17)
Multiple projects are showing positive and possible expansions for this gold miner. More >

Shining a Light on an Out-of-Favor Oil Stock
Source: Clive Maund for Streetwise Reports  (12/7/17)
Technical analyst Clive Maund charts an oil and gas explorer that he believes is under the radar of most investors. More >

Immuno-Oncology Candidate Yields 'Impressive' Early Clinical Results
Source: Streetwise Reports  (12/6/17)
This biotech reported positive results in a Phase 1b trial for its ovarian cancer immuno-oncology drug-delivery candidate, prompting increases in share price targets from a pair of analysts. More >